Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

KPRX

+ Watchlist+ Portfolio

Kiora Pharmaceuticals, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.93
52-Week Range
$0.78 – $2.91
Market Cap
$3.65M
P/E (TTM)
—
EPS (TTM)
-2.72
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.24
PEG Ratio
—
Return on Equity
-67.70%
Return on Assets
-21.30%
Gross Margin
-271.42%
Operating Margin
-890.17%
Profit Margin
0.00%
Current Ratio
7.91
Debt/Equity
0.02
Total Debt
$286.79K
Free Cash Flow
$-4.89M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$-12.35M

Market Snapshot

About

Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing therapies for ophthalmic diseases. The company focuses on treating retinal diseases and other sight-threatening eye conditions. Their pipeline includes novel small molecule compounds and drug delivery technologies designed to address significant unmet medical needs in ophthalmology.